Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00864_DB01072_nanopub.RAbapqI5YTTEAYiS5sEaxmAg0Q7sHqza0jRHFrIgIAwuw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00864_DB01072 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00864_DB01072 label "DDI between Tacrolimus and Atazanavir - The protease inhibitor, Atazanavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Atazanavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00864_DB01072]" assertion.
- drugbank_resource:DB00864_DB01072 identifier "drugbank_resource:DB00864_DB01072" assertion.
- drugbank_resource:DB00864_DB01072 title "DDI between Tacrolimus and Atazanavir - The protease inhibitor, Atazanavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Atazanavir therapy is initiated, discontinued or altered." assertion.
- drugbank:DB00864 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00864_DB01072 assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00864_DB01072 assertion.